ethyl (2-amino-4-methyl-1,3-thiazol-5-yl)acetate, 95.0%, 1g

(2S,4R)-1-((S)-14-amino-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamidehydrochloride, 95%, 1g

(S)-Oxetane-2-carboxylic acid, 97+%, 1g

Pipette microlitre monocanal Transferpette® S variable, 500 à 5000 µl, D-5000, 1 pièce

3-(Bromomethyl)bicyclo[1.1.1]pentan-1-ol, 98%, 100mg

4-Bromothieno[2,3-c]pyridine-2-carboxylic acid, 95+%, 1g

2-(9,10-Di(naphthalen-2-yl)anthracen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

3-(4-bromophenyl)-3-hydroxy-1-phenylprop-2-en-1-one, 95%, 1g

2-(Methoxymethyl)-4-(trifluoromethyl)benzoic acid, 98%, 5g

4-CHLORO-7-METHYL-5,7-DIHYDRO-6H-PYRROLO[2,3-D]PYRIMIDIN-6-ONE, 95.0%, 1g

8-Methyl-3,4-dihydro-2h-1-benzopyran-4-amine hydrochloride, 95+%, 250mg

6-Chloro-5-nitropicolinic acid, 95.0%, 25g

N-(2-furylmethyl)-3-oxobutanamide, 95.0%, 1g